Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical versus systemic treatment for localized neuropathic pain
2018-003617-17Phase 4Completed
- Sponsor
- Antwerp University Hospital
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Neuralgia comparing Lidocaine 5% patch, Capsaicin 8% patch and Oral pregabalin (3 arms). Primary endpoint: Change in EQ-5D-5L from baseline to week 6. Started Oct 2018; status: completed.
02
Drugs
lidocainecapsaicinpregabalin
03
Conditions
Neuralgia
Beyond the preview
Go deeper on 2018-003617-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003617-17.